Evidence map›Paper›PMID 23441690›Full record

ArticleCNS neuroscience & therapeutics2013

Effects of combination therapy with levamlodipine and bisoprolol on stroke in rats.

Huan Gui, Yong-Fei Guo, Xia Liu, Jing-Ming Zhang, Yan-Ling Yang, Gao-Zhong Huang, Jian-Guo Liu

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Neutrophil βBritish journal of pharmacology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Huan GuiDepartment of Pharmacology, Second Military Medical University, Shanghai, China.
Yong-Fei Guo
Xia Liu
Jing-Ming Zhang
Yan-Ling Yang
Gao-Zhong Huang
Jian-Guo Liu
Second Military Medical University · CNShanghai Institute of Pharmaceutical Industry · CNShanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo examine the effects of combination with levamlodipine and bisoprolol on stroke in rats.

methodsFor acute study, Systolic blood pressure (SBP) and heart period (HP) were monitored in conscious stroke prone-spontaneously hypertensive rats (SHR-SP) and sinoaortic denervation (SAD) rats before and after intragastric administration of either drug at a single dose. Rats were subjected to middle cerebral arterial occlusion (MCAO) half an hour after drug administration; sacrificed 24 h later to measure the infarct size. For long-term study, drugs (either alone or in combination) were delivered via food to SHR-SP. The survival time was recorded.

resultsSBP was significantly reduced by combination therapy both in SHR-SP and SAD rats. Neutralization on heart rate (HR) was observed in combination. The drug combination increased baroreflex sensitivity (BRS) and reduced SBP variability (SBPV). In chronic experiments, the lifespan of SHR-SP rats exposed to the drug combination was longer than that in rats exposed to either drug alone. The infarct area was the smallest in subjects receiving drug combination in SD rats both with and without SAD.

conclusionCombined use of levamlodipine and bisoprolol produced better protection against stroke.

Indexed as

AnimalsAntihypertensive AgentsBaroreflexBisoprololDrug Therapy, CombinationHeart RateMaleNiacinRatsRats, Inbred SHRRats, Sprague-DawleyStrokeSystoleAntihypertensive AgentsBisoprolollevamlodipineNiacin

Identifiers

PMID23441690
PMCPMC6493655
OpenAlexW2061306283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.